Heart 1998;79:560-567 ( June )
Differential effects of defibrillation on systemic and cardiac sympathetic activity
a Medizinische Klinik II, Medizinische Universität zu
Lübeck, Ratzeburger Alle 160, 23538 Lübeck, Germany, b Institut für Pharmakologie, Medizinische Universität zu
Lübeck
Correspondence to: Dr Bode.
Accepted for publication 19 January 1998
Objective
To assess the effect of defibrillation
shocks on cardiac and circulating catecholamines.
Design
Prospective examination of
myocardial catecholamine balance during dc shock by simultaneous
determination of arterial and coronary sinus plasma concentrations.
Internal countershocks (10-34 J) were applied in 30 patients after
initiation of ventricular fibrillation for a routine implantable
cardioverter defibrillator test. Another 10 patients were externally
cardioverted (50-360 J) for atrial fibrillation.
Main outcome measures
Transcardiac
noradrenaline, adrenaline, and lactate gradients immediately after the shock.
Results
After internal shock,
arterial noradrenaline increased from a mean (SD) of 263 (128) pg/ml
at baseline to 370 (148) pg/ml (p = 0.001), while coronary sinus
noradrenaline fell from 448 (292) to 363 (216) pg/ml (p = 0.01),
reflecting a shift from cardiac net release to net uptake. After
external shock delivery, there was a similar increase in arterial
noradrenaline, from 260 (112) to 459 (200) pg/ml (p = 0.03), while
coronary sinus noradrenaline remained unchanged. Systemic adrenaline
increased 11-fold after external shock (p = 0.01), outlasting the
threefold rise following internal shock (p = 0.001). In both groups,
a negative transmyocardial adrenaline gradient at baseline decreased
further, indicating enhanced myocardial uptake. Cardiac lactate
production occurred after ventricular fibrillation and internal shock,
but not after external cardioversion, so the neurohumoral changes
resulted from the defibrillation process and not from alterations in
oxidative metabolism.
Conclusions
A dc shock induces marked
systemic sympathoadrenal and sympathoneuronal activation, but
attenuates cardiac sympathetic activity. This might promote the
transient myocardial depression observed after electrical discharge to
the heart.
© 1998 by Heart
This article has been cited by other articles:
-
Cevik, C., Perez-Verdia, A., Nugent, K.
(2009). Implantable cardioverter defibrillators and their role in heart failure progression. Europace
11: 710-715
[Abstract] [Full Text] -
Shah, K. B., Gottlieb, S. S., Steinbeck, G., Andresen, D., Senges, J., Micheletta, F., Natoli, S., Iuliano, L., Hohnloser, S. H., Connolly, S. J., Gent, M., the DINAMIT Investigators,
(2005). Implantable Cardioverter-Defibrillator Therapy after Myocardial Infarction. NEJM
352: 1039-1041
[Full Text] -
Ladwig, K.-H., Marten-Mittag, B., Deisenhofer, I., Hofmann, B., Schapperer, J., Weyerbrock, S., Schmitt, C.
(2003). Exaggerated Electrodermal Startle Responses After Intracardiac Shock Discharges in Patients With Implanted Cardioverter Defibrillators. Psychosom. Med.
65: 222-228
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
